Atrial fibrosis and the mechanisms of atrial fibrillation
- PMID: 17336879
- PMCID: PMC1850572
- DOI: 10.1016/j.hrthm.2006.12.040
Atrial fibrosis and the mechanisms of atrial fibrillation
Abstract
Atrial fibrillation (AF) is commonly associated with congestive heart failure (CHF), and CHF has been shown to be associated with atrial structural remodeling resulting in fibrosis. Atrial interstitial fibrosis has been seen in patients with CHF and in animal models of pacing-induced heart failure. With atrial fibrosis, conduction abnormalities result in increased AF vulnerability. The mechanism of AF associated with CHF is under debate, as both focal and reentrant mechanisms have been observed in animal models of CHF. However, recent studies using frequency-domain analysis have shown that the AF within this model is characterized by discrete, stable, high-frequency areas. The precise signaling processes involved in the development of atrial fibrosis are unknown. Angiotensin appears to play a role, as inhibition of angiotensin-converting enzyme (or angiotensin-receptor blocker) blunts atrial fibrosis in animal models of heart failure and decreases the incidence of AF in patients with heart failure. Transforming growth factor-beta (TGF-beta) also appears to play an important role. Mouse models that overexpress TGF-beta1 have profound atrial fibrosis and AF (with normal ventricles). Heart failure in canine models also produces increases in atrial TGF-beta1 expression, and inhibition of this expression prevents atrial fibrosis and the development of a substrate for AF. Atrial fibrosis appears to play a role in the development of a vulnerable substrate for AF, especially in the setting of CHF.
Similar articles
-
Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.Circulation. 1999 Jul 6;100(1):87-95. doi: 10.1161/01.cir.100.1.87. Circulation. 1999. PMID: 10393686
-
High resolution mapping of the pulmonary vein and the vein of Marshall during induced atrial fibrillation and atrial tachycardia in a canine model of pacing-induced congestive heart failure.J Am Coll Cardiol. 2003 Jul 16;42(2):348-60. doi: 10.1016/s0735-1097(03)00586-2. J Am Coll Cardiol. 2003. PMID: 12875775
-
Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.Circ Res. 2009 Dec 4;105(12):1213-22. doi: 10.1161/CIRCRESAHA.108.183400. Epub 2009 Oct 29. Circ Res. 2009. PMID: 19875729
-
Atrial fibrillation and atrial fibrosis.J Cardiovasc Pharmacol. 2011 Jun;57(6):625-9. doi: 10.1097/FJC.0b013e3182073c78. J Cardiovasc Pharmacol. 2011. PMID: 21633248 Review.
-
Upstream therapy for atrial fibrillation in heart failure.Heart Fail Clin. 2013 Oct;9(4):417-25, viii. doi: 10.1016/j.hfc.2013.07.010. Epub 2013 Aug 12. Heart Fail Clin. 2013. PMID: 24054475 Review.
Cited by
-
Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management.Rev Cardiovasc Med. 2024 Apr 9;25(4):143. doi: 10.31083/j.rcm2504143. eCollection 2024 Apr. Rev Cardiovasc Med. 2024. PMID: 39076563 Free PMC article. Review.
-
Synergistic Effects of Weight Loss and Catheter Ablation: Can microRNAs Serve as Predictive Biomarkers for the Prevention of Atrial Fibrillation Recurrence?Int J Mol Sci. 2024 Apr 25;25(9):4689. doi: 10.3390/ijms25094689. Int J Mol Sci. 2024. PMID: 38731908 Free PMC article. Review.
-
Corilagin inhibits angiotensin II-induced atrial fibrosis and fibrillation in mice through the PI3K-Akt pathway.Iran J Basic Med Sci. 2024;27(6):717-724. doi: 10.22038/IJBMS.2024.73281.15928. Iran J Basic Med Sci. 2024. PMID: 38645493 Free PMC article.
-
Improvement in Atrioventricular Conduction Using Cardioneuroablation Performed Immediately after Pulmonary Vein Isolation.Healthcare (Basel). 2024 Mar 27;12(7):728. doi: 10.3390/healthcare12070728. Healthcare (Basel). 2024. PMID: 38610150 Free PMC article.
-
Collagen type V, interstitial fibrosis and the substrate for atrial fibrillation.Int J Cardiol Heart Vasc. 2024 Feb 12;50:101356. doi: 10.1016/j.ijcha.2024.101356. eCollection 2024 Feb. Int J Cardiol Heart Vasc. 2024. PMID: 38419609 Free PMC article. No abstract available.
References
-
- Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004 Dec 2;351(23):2373–2383. - PubMed
-
- Spach MS, Boineau JP. Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias . Pacing Clin Electrophysiol. 1997 Feb;20(2 Pt 2):397–413. - PubMed
-
- Spach MS, Josephson ME. Initiating reentry: the role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol. 1994 Feb;5(2):182–209. - PubMed
-
- Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997 Aug 19;96(4):1180–1184. - PubMed
-
- Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res. 2002 May;54(2):361–379. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical